|
|
||||||||
Division of Cardiology, Beth Israel Medical Center, New York, New York
Correspondence: For correspondence or reprints contact: Bibiana Nagy, MD, Beth Israel Med. Ctr., First Ave at 16th St., New York, NY 10003.
ABSTRACT
A resting perfusion defect detected during radioisotope myocardial perfusion imaging is generally thought to represent myocardial infarction. The administration of nitroglycerin during cardiac PET imaging results in improved resting defects, which suggests transiently abnormal resting perfusion with silent myocardial ischemia.
Key Words: myocardial perfusion imaging positron emission tomography myocardial ischemia
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |